Haptic Device for Numbness
Trial Summary
What is the purpose of this trial?
The study will explore the use of a haptic device for sensory substitution in individuals with a movement disorder that has caused loss of plantar sensation. The haptic device consists of two components. The first element is a flexible insole with embedded pressure-sensing elements that transmit the spatial patterns of applied foot pressure over time. The second element is a haptic receiver with embedded actuators that vibrate or heat up in proportion to the transmitted pressure patterns, thus substituting the patient's lost plantar sensation.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Haptic Device, Multimodal Haptic Feedback Device, Plantar Sensory Substitution Device for numbness?
Research on similar haptic feedback systems for lower-limb prostheses shows that these devices can improve balance and stability by providing sensory feedback, as seen in studies where users demonstrated improved gait stability and reduced variability in stride length and step width. Additionally, haptic feedback systems have been effective in helping users perceive directional stimuli and force levels accurately, suggesting potential benefits for addressing numbness.12345
Is the Haptic Device for Numbness safe for humans?
How is the Haptic Device treatment for numbness different from other treatments?
The Haptic Device for numbness is unique because it uses sensory substitution, translating force information from the foot into tactile feedback on the thigh, which helps users perceive sensations they otherwise cannot feel. This approach is different from traditional treatments as it provides a novel way to restore sensory feedback through haptic technology, which is not commonly used for numbness.13479
Research Team
Arun Jayaraman, PT, PhD
Principal Investigator
Shirley Ryan AbilityLab
Eligibility Criteria
This trial is for individuals with movement disorders leading to reduced sensation or numbness in the soles of their feet. Participants should be able to walk and have a stable condition, but specific details on age or other health requirements are not provided.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use the haptic device to complete standardized balance and walking tasks with and without sensory substitution
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Haptic Device
Find a Clinic Near You
Who Is Running the Clinical Trial?
Shirley Ryan AbilityLab
Lead Sponsor
Querrey Simpson Institute for Bioelectronics
Collaborator
Northwestern University
Collaborator